Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$927K Buy
+29,890
New +$1.02M 0.62% 23
2018
Q1
Sell
-7,086
Closed -$244K 428
2017
Q4
$244K Buy
+7,086
New +$242K 0.03% 288
2017
Q1
Sell
-813
Closed -$25.6K 239
2016
Q4
$25K Buy
+813
New +$24.8K 0.01% 138
2016
Q2
Sell
-34,277
Closed -$1.09M 725
2016
Q1
$964K Buy
+34,277
New +$979K 0.04% 198
2015
Q3
Sell
-10,466
Closed -$336K 801
2015
Q2
$333K Buy
+10,466
New +$341K 0.01% 548
2015
Q1
Sell
-11,390
Closed -$362K 858
2014
Q4
$337K Sell
11,390
-17,941
-61% -$514K 0.01% 554
2014
Q3
$823K Buy
29,331
+27,571
+1,567% +$774K 0.03% 294
2014
Q2
$50K Sell
1,760
-8,390
-83% -$239K ﹤0.01% 711
2014
Q1
$309K Buy
10,150
+4,412
+77% +$132K 0.01% 437
2013
Q4
$167K Buy
+5,738
New +$167K 0.02% 552

Other funds holding PFE

Jump Trading's PFE Position: Q2 2020 in Review

Jump Trading opened a new position in Pfizer (PFE) in Q2 2020: 29,890 shares worth $927K. The stake represents 0.62% of the portfolio and ranks #23 among its holdings. This is a return to the name: Jump Trading previously reported a position in PFE as recently as Q4 2017.

Jump Trading first reported a position in PFE in Q4 2013 and has held it in 10 quarters since. The position peaked at $964K in Q1 2016. 2,442 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Jump Trading held 29,890 shares of Pfizer worth $927K as of Q2 2020.
  • Pfizer was a new Jump Trading position in Q2 2020.
  • Pfizer made up 0.62% of Jump Trading's portfolio in Q2 2020, its #23 holding.
  • Jump Trading first reported a position in Pfizer in Q4 2013 and has held it in 10 quarters since.
  • Jump Trading's Pfizer position peaked at $964K in Q1 2016.
  • 2,442 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Jump Trading's 13F filing for Q2 2020, filed 3 Aug 2020.